Xinda Compounding Hot Melt Extrusion for the Pharma Industry



Hot-melt extrusion is a proven manufacturing process that complies with FDA Process Analytical Technology (PAT) goals for designing, analyzing and controlling manufacturing process programs.
This technology can be used to produce granules, pellets, immediate-release tablets, controlled-release tablets, and Pellicle. At present, many drugs have been approved for marketing in foreign countries using HME technology.
Feeder: weighing type, weight-loss type, forced type, etc. are available in different models and sizes according to the configuration of the extruder
Cutter: air-cooled mold surface granulation, water-cooled granulation, cooling conveyor belt granulation, various models and sizes available Granulator: roller granulator, high-speed pill-making machine, multiple-shape tablet granulation optional
Tablet press: continuous tablet press
Conveyor belt: water cooling/air cooling, laboratory/production multiple models optional solation box: can be used to place16mm, 20mm series extruders, and their accessories
Specification | Pharma 11mm | Pharma 16mm | Pharma 20mm |
Output | 0-1kg/h | 1-3kg/h | 3-10kg/h |
Powder | 1.5kw | 2kw | 4kw |

High shear force mixing and extrusion to enhance drug dissolution and stability
Continuous process, more stable quality support online detection
No water or solvent is required, supports the production of moisture-sensitive materials
Fewer process steps and high repeatability!



Pellets Implant rods Medical plastics
Sustained release or delayed-release preparations
Insoluble Api &masking Apy bad smells
Skin, mucous membrane, or wound care filmes
localized release formulation
Medical polymer materials( PVC,PS,PAM,PvA,implants materials; PLA,PLGA )
Food: Plant protein meat, etc.
Other formulation (research development.)
